IQCB1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.845000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.381800E-01
Normal-vs-Stage2
3.944200E-01
Normal-vs-Stage3
1.389580E-01
Normal-vs-Stage4
6.607400E-01
Stage1-vs-Stage2
7.262600E-01
Stage1-vs-Stage3
6.880200E-02
Stage1-vs-Stage4
2.649800E-01
Stage2-vs-Stage3
1.682610E-01
Stage2-vs-Stage4
1.130000E-01
Stage3-vs-Stage4
9.197500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.905000E-01
Normal-vs-AfricanAmerican
2.238200E-01
Normal-vs-Asian
1.094550E-01
Caucasian-vs-AfricanAmerican
9.024000E-01
Caucasian-vs-Asian
5.778000E-01
AfricanAmerican-vs-Asian
7.039000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.849800E-01
Normal-vs-Female
3.863200E-01
Male-vs-Female
9.757600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.024400E-01
Normal-vs-Age(41-60Yrs)
4.777200E-01
Normal-vs-Age(61-80Yrs)
3.400200E-01
Normal-vs-Age(81-100Yrs)
4.594200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.303000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.601600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.827200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.063900E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.179000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.369230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.623400E-01
Normal-vs-Daily Drinker
3.549400E-01
Normal-vs-Weekly Drinker
8.332300E-02
Normal-vs-Occasional Drinker
4.363400E-01
Normal-vs-Social Drinker
4.049400E-01
Non Drinker-vs-Daily Drinker
8.858000E-01
Non Drinker-vs-Weekly Drinker
9.971600E-01
Non Drinker-vs-Occasional Drinker
3.344000E-01
Non Drinker-vs-Social Drinker
6.038000E-01
Daily Drinker-vs-Weekly Drinker
9.166000E-01
Daily Drinker-vs-Occasional Drinker
3.259000E-01
Daily Drinker-vs-Social Drinker
5.626200E-01
Weekly Drinker-vs-Occasional Drinker
4.598200E-01
Weekly Drinker-vs-Social Drinker
6.889600E-01
Occasional Drinker-vs-Social Drinker
7.279200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.332400E-01
Normal-vs-Grade 2
3.538200E-02
Normal-vs-Grade 3
2.576100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.465840E-02
Grade 1-vs-Grade 3
6.440700E-03
Grade 1-vs-Grade 4
2.332400E-01
Grade 2-vs-Grade 3
4.037200E-01
Grade 2-vs-Grade 4
3.538200E-02
Grade 3-vs-Grade 4
2.576100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.505600E-01
Normal-vs-NonDiabetic
3.773800E-01
Diabetic-vs-NonDiabetic
5.120600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.485600E-01
Normal-vs-NoPancreatitis
3.619600E-01
Pancreatitis-vs-NoPancreatitis
2.755800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.069600E-01
Normal-vs-N1
3.794000E-01
N0-vs-N1
5.384200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.121800E-01
Normal-vs-TP53-NonMutant
3.641800E-01
TP53-Mutant-vs-TP53-NonMutant
4.102400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
